The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective

por Leelarathna, Lalantha, Ashley, Donna, Fidler, Carrie, Parekh, Witesh
Publicado 2018

Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK

por Thalange, Nandu, Gundgaard, Jens, Parekh, Witesh, Tutkunkardas, Deniz
Publicado 2019

Cost of epilepsy-related health care encounters in the United States

por Borghs, Simon, Beaty, Silky, Parekh, Witesh, Kalilani, Linda, Boudiaf, Nada, Loewendorf, Andrea
Publicado 2020

Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

por Pöhlmann, Johannes, Montagnoli, Roberta, Lastoria, Giusi, Parekh, Witesh, Markert, Marie, Hunt, Barnaby
Publicado 2019

The Economic Burden of Insulin-Related Hypoglycemia in Spain

por Parekh, Witesh, Hoskins, Nicki, Baker-Knight, James, Ramirez de Arellano, Antonio, Mezquita Raya, Pedro
Publicado 2017

Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain

por Parekh, Witesh, Hoskins, Nicki, Baker-Knight, James, Ramirez de Arellano, Antonio, Mezquita Raya, Pedro
Publicado 2017

The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System

por Parekh, Witesh, Streeton, Sophie E., Baker-Knight, James, Montagnoli, Roberta, Nicoziani, Paolo, Marchesini, Giulio
Publicado 2018